We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Blood Test Detects ALS with 98% Accuracy

By LabMedica International staff writers
Posted on 17 Sep 2024
Print article
Image: Extracellular vesicles are nano-sized particles that circulate in the blood, are secreted by all cells, and contain microRNA (Photo courtesy of Paul Cox, Brain Chemistry Labs)
Image: Extracellular vesicles are nano-sized particles that circulate in the blood, are secreted by all cells, and contain microRNA (Photo courtesy of Paul Cox, Brain Chemistry Labs)

Amyotrophic lateral sclerosis (ALS) is presently diagnosed via a neurologist’s clinical examination, but differentiating it from other neurological conditions requires tracking symptom progression, which can be challenging. Given that the average survival time for ALS is about three years, many patients experience significant deterioration before receiving a confirmed diagnosis. Misdiagnosis rates can be as high as 68%, which delays treatment and causes patients to be shuffled between specialists, leading to increased anxiety, unnecessary interventions, and higher healthcare costs. Now, a blood test for diagnosing ALS could be available in as little as two years.

Researchers at Brain Chemistry Labs (Jackson, WY, USA) have discovered an ALS-specific biomarker, an "ALS fingerprint," in the blood. This biomarker, made up of eight microRNAs (miRNAs), can be detected with a simple blood test. The team utilized next-generation sequencing and real-time PCR to analyze blood samples from individuals with ALS, Primary Lateral Sclerosis (PLS), Parkinson’s disease (PD), and healthy controls. Their findings, published in Brain Communications, show that the eight-microRNA ALS fingerprint can diagnose ALS with up to 98% accuracy and distinguish it from PLS and PD.

To ensure the reliability of the test, it was validated across four different patient groups, in two separate laboratories, using various technicians and collection methods. The ALS fingerprint consistently produced reliable results. Researchers believe that this blood test could aid neurologists in diagnosing ALS, complementing current clinical evaluations. A simple blood test for ALS could be a breakthrough, as it would speed up diagnosis, reduce patient anxiety, lower healthcare costs, and facilitate the development of new treatments. Given the high misdiagnosis rate, a negative result could also be incredibly useful. Brain Chemistry Labs aims to partner with a diagnostic company and make this test widely available to neurologists within the next 18 to 24 months.

“Faster diagnoses will allow for earlier treatment, which will improve patient outcomes,” said Sandra Banack, lead author of the study.

Related Links:
Brain Chemistry Labs

New
Gold Member
Chagas Disease Test
CHAGAS Cassette
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
MRSA/SA Detection Kit
MRSA/SA ELITe MGB Kit

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: The new method uses DNA sequencing to measure metabolites (Photo courtesy of 123RF)

New Metabolite Detection Method Using DNA Sequencing Could Transform Diagnostics

Metabolites play a vital role as biomarkers that provide insights into our health, and when their levels go awry, it can lead to diseases such as diabetes and phenylketonuria. Quantifying metabolites remains... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.